The North America Nebulizer Market would witness market growth of 5.0% CAGR during the forecast period (2022-2028).
Both nebulizers and inhalers have a number of similarities, including the fact that they both work to deliver medication directly into the lungs in order to facilitate better breathing. However, there are a few key distinctions between the two. A metered-dose inhaler, often known as an MDI, and a dry-powder inhaler are the two varieties of inhalers that are available. The most common kind of inhaler that people use is called an MDI. In order to use one, you have to breathe in a certain quantity of medication via a mouthpiece. It is possible to get inhalers that have a spacer, which simplifies the process of inhaling the drug.
A dry-powder inhaler is similar to this, with the exception that the drug contained inside the inhaler is in powder form. In order to properly inhale the powdered medication, it is necessary for the user to take rapid and deep breaths. This helps to move the medication to the inside of the lungs. The capacity to inhale the medication into the deepest parts of the lungs is necessary for both kinds. It's possible that this might be difficult for certain youngsters and those who have severe respiratory illnesses.
Since 2009, there has been a 14.4 million, or 36%, rise in the number of older Americans, although there have only been a 3% growth in the population of those under the age of 65. The prevalence of some illnesses, such as persistent asthma and other respiratory problems, is expected to increase throughout the area as the number of older people continues to grow. Because of this, there will be an increased demand for nebulizers throughout the North American area.
The North America market dominated the Global Nebulizer Market by Region in 2021 and would continue to be a dominant market till 2028; thereby, achieving a market value of $461.9 Million by 2028. The Europe market would exhibit a CAGR of 5.2% during (2022 - 2028). Additionally, The Asia Pacific market is anticipated to grow at a CAGR of 6.1% during (2022 - 2028).
Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on End-use, the market is segmented into Hospitals & Clinics, Emergency Centers and Home Healthcare. Based on Application, the market is segmented into COPD, Asthma, Cystic Fibrosis and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Nebulizer Market is Predict to reach $1.4 Billion by 2028, at a CAGR of 5.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Koninklijke Philips N.V., Drive DeVilbiss Healthcare (Medical Depot, Inc.), Beurer GmBH, Vectura Group Plc (Philip Morris International, Inc.), Allied Healthcare Products, Inc., GE HealthCare Technologies, Inc., PARI GmbH, Aerogen Ltd.
By Type
By End-use
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 